Boston recalls 200 Taxus stents in the US
This article was originally published in Clinica
Boston Scientific has voluntarily recalled in the US around 200 of its drug-eluting Taxus stents after one patient died and 16 were seriously injured because of a problem with the mechanism used to implant the device.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.